JPWO2018216757A1 - Substance measurement method that measures the target substance as a coenzyme - Google Patents
Substance measurement method that measures the target substance as a coenzyme Download PDFInfo
- Publication number
- JPWO2018216757A1 JPWO2018216757A1 JP2019520301A JP2019520301A JPWO2018216757A1 JP WO2018216757 A1 JPWO2018216757 A1 JP WO2018216757A1 JP 2019520301 A JP2019520301 A JP 2019520301A JP 2019520301 A JP2019520301 A JP 2019520301A JP WO2018216757 A1 JPWO2018216757 A1 JP WO2018216757A1
- Authority
- JP
- Japan
- Prior art keywords
- substance
- measured
- measurement
- enzyme
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 title claims abstract description 60
- 239000005515 coenzyme Substances 0.000 title claims abstract description 28
- 239000013076 target substance Substances 0.000 title claims abstract description 24
- 238000000691 measurement method Methods 0.000 title claims description 23
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 51
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims abstract description 50
- 238000000034 method Methods 0.000 claims abstract description 50
- 238000005259 measurement Methods 0.000 claims abstract description 49
- 229960003495 thiamine Drugs 0.000 claims abstract description 41
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims abstract description 41
- 235000019157 thiamine Nutrition 0.000 claims abstract description 40
- 239000011721 thiamine Substances 0.000 claims abstract description 40
- 102000004190 Enzymes Human genes 0.000 claims abstract description 35
- 108090000790 Enzymes Proteins 0.000 claims abstract description 35
- 238000006243 chemical reaction Methods 0.000 claims abstract description 19
- 239000000758 substrate Substances 0.000 claims abstract description 14
- 108010042687 Pyruvate Oxidase Proteins 0.000 claims abstract description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 25
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 25
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical group C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 23
- 238000002835 absorbance Methods 0.000 claims description 14
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 12
- 230000008859 change Effects 0.000 claims description 10
- 102000003855 L-lactate dehydrogenase Human genes 0.000 claims description 8
- 108700023483 L-lactate dehydrogenases Proteins 0.000 claims description 8
- 229950006238 nadide Drugs 0.000 claims description 8
- 102000003992 Peroxidases Human genes 0.000 claims description 7
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 7
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 claims description 5
- 230000003197 catalytic effect Effects 0.000 claims description 4
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 claims description 3
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 abstract description 10
- 229940107700 pyruvic acid Drugs 0.000 abstract description 5
- 239000000523 sample Substances 0.000 description 43
- 239000000047 product Substances 0.000 description 31
- 239000011678 thiamine pyrophosphate Substances 0.000 description 24
- 235000008170 thiamine pyrophosphate Nutrition 0.000 description 22
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 22
- 239000000243 solution Substances 0.000 description 18
- 238000004128 high performance liquid chromatography Methods 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 7
- -1 phosphate ester Chemical class 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 6
- 150000003014 phosphoric acid esters Chemical class 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 229960002363 thiamine pyrophosphate Drugs 0.000 description 6
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 5
- 238000011481 absorbance measurement Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 5
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 5
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 5
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 5
- 229940076788 pyruvate Drugs 0.000 description 5
- 239000012086 standard solution Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 235000020955 thiamine monophosphate Nutrition 0.000 description 4
- 239000011621 thiamine monophosphate Substances 0.000 description 4
- IWLROWZYZPNOFC-UHFFFAOYSA-O thiamine triphosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N IWLROWZYZPNOFC-UHFFFAOYSA-O 0.000 description 4
- GUGWNSHJDUEHNJ-UHFFFAOYSA-N thiamine(1+) monophosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N GUGWNSHJDUEHNJ-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 3
- 108090000489 Carboxy-Lyases Proteins 0.000 description 3
- 102000004031 Carboxy-Lyases Human genes 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- LIPOUNRJVLNBCD-UHFFFAOYSA-N acetyl dihydrogen phosphate Chemical compound CC(=O)OP(O)(O)=O LIPOUNRJVLNBCD-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- FAXWFCTVSHEODL-UHFFFAOYSA-N 2,4-dibromophenol Chemical compound OC1=CC=C(Br)C=C1Br FAXWFCTVSHEODL-UHFFFAOYSA-N 0.000 description 2
- ZLQNJZKBJSMXCJ-UHFFFAOYSA-N 3-(n-ethyl-3-methoxyanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC=CC(OC)=C1 ZLQNJZKBJSMXCJ-UHFFFAOYSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- SDKQRNRRDYRQKY-UHFFFAOYSA-N Dioxacarb Chemical compound CNC(=O)OC1=CC=CC=C1C1OCCO1 SDKQRNRRDYRQKY-UHFFFAOYSA-N 0.000 description 2
- AGMJSPIGDFKRRO-YFKPBYRVSA-N L-topaquinone Chemical compound OC(=O)[C@@H](N)CC1=CC(=O)C(O)=CC1=O AGMJSPIGDFKRRO-YFKPBYRVSA-N 0.000 description 2
- OAZWDJGLIYNYMU-UHFFFAOYSA-N Leucocrystal Violet Chemical compound C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 OAZWDJGLIYNYMU-UHFFFAOYSA-N 0.000 description 2
- WZKXBGJNNCGHIC-UHFFFAOYSA-N Leucomalachite green Chemical compound C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)N(C)C)C1=CC=CC=C1 WZKXBGJNNCGHIC-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 description 2
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 description 2
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 229950001485 cocarboxylase Drugs 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 108010077372 mast cell degranulating peptide Proteins 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 229920002113 octoxynol Polymers 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- IRQRBVOQGUPTLG-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 IRQRBVOQGUPTLG-UHFFFAOYSA-M 0.000 description 2
- AYEKOFBPNLCAJY-UHFFFAOYSA-O thiamine pyrophosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N AYEKOFBPNLCAJY-UHFFFAOYSA-O 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- OAJLVMGLJZXSGX-SLAFOUTOSA-L (2s,3s,4r,5r)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7 Chemical compound [Co+3].O[C@H]1[C@@H](O)[C@@H]([CH2-])O[C@@H]1N1C2=NC=NC(N)=C2N=C1.[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O OAJLVMGLJZXSGX-SLAFOUTOSA-L 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- ZPGZNKGKCSYBGK-UHFFFAOYSA-N 1-n-[4-(dimethylamino)phenyl]-4-n,4-n-dimethylbenzene-1,4-diamine Chemical compound C1=CC(N(C)C)=CC=C1NC1=CC=C(N(C)C)C=C1 ZPGZNKGKCSYBGK-UHFFFAOYSA-N 0.000 description 1
- LINPIYWFGCPVIE-UHFFFAOYSA-N 2,4,6-trichlorophenol Chemical compound OC1=C(Cl)C=C(Cl)C=C1Cl LINPIYWFGCPVIE-UHFFFAOYSA-N 0.000 description 1
- HFZWRUODUSTPEG-UHFFFAOYSA-N 2,4-dichlorophenol Chemical compound OC1=CC=C(Cl)C=C1Cl HFZWRUODUSTPEG-UHFFFAOYSA-N 0.000 description 1
- HOLHYSJJBXSLMV-UHFFFAOYSA-N 2,6-dichlorophenol Chemical compound OC1=C(Cl)C=CC=C1Cl HOLHYSJJBXSLMV-UHFFFAOYSA-N 0.000 description 1
- XUJZNKFIBZHDKL-UHFFFAOYSA-N 2-[[3,7-bis(dimethylamino)phenothiazine-10-carbonyl]amino]acetic acid Chemical class C1=C(N(C)C)C=C2SC3=CC(N(C)C)=CC=C3N(C(=O)NCC(O)=O)C2=C1 XUJZNKFIBZHDKL-UHFFFAOYSA-N 0.000 description 1
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 description 1
- 108010044740 2-hydroxy-3-oxoadipate synthase Proteins 0.000 description 1
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 description 1
- 108010021680 2-oxoglutarate decarboxylase Proteins 0.000 description 1
- 108010045437 2-oxoglutarate synthase Proteins 0.000 description 1
- LWKJNIMGNUTZOO-UHFFFAOYSA-N 3,5-dichloro-2-hydroxybenzenesulfonic acid Chemical compound OC1=C(Cl)C=C(Cl)C=C1S(O)(=O)=O LWKJNIMGNUTZOO-UHFFFAOYSA-N 0.000 description 1
- VPOMSPZBQMDLTM-UHFFFAOYSA-N 3,5-dichlorophenol Chemical compound OC1=CC(Cl)=CC(Cl)=C1 VPOMSPZBQMDLTM-UHFFFAOYSA-N 0.000 description 1
- XEZFKMUDMLXWAW-UHFFFAOYSA-N 3,7-bis(dimethylamino)-n-methylphenothiazine-10-carboxamide Chemical compound CN(C)C1=CC=C2N(C(=O)NC)C3=CC=C(N(C)C)C=C3SC2=C1 XEZFKMUDMLXWAW-UHFFFAOYSA-N 0.000 description 1
- AOTXQRRUWFSXCN-UHFFFAOYSA-N 3-(3,5-dimethoxyanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound COC1=CC(NCC(O)CS(O)(=O)=O)=CC(OC)=C1 AOTXQRRUWFSXCN-UHFFFAOYSA-N 0.000 description 1
- BTIDJAQNJLWPTI-UHFFFAOYSA-N 3-(n-ethyl-3,5-dimethoxyanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC(OC)=CC(OC)=C1 BTIDJAQNJLWPTI-UHFFFAOYSA-N 0.000 description 1
- CDGBQMHYFARRCC-UHFFFAOYSA-N 3-(n-ethyl-3,5-dimethylanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC(C)=CC(C)=C1 CDGBQMHYFARRCC-UHFFFAOYSA-N 0.000 description 1
- STBWJPWQQLXSCK-UHFFFAOYSA-N 3-(n-ethyl-3-methoxyanilino)propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCN(CC)C1=CC=CC(OC)=C1 STBWJPWQQLXSCK-UHFFFAOYSA-N 0.000 description 1
- IBSUMVZKDLDAEK-UHFFFAOYSA-N 3-(n-ethyl-3-methylanilino)propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCN(CC)C1=CC=CC(C)=C1 IBSUMVZKDLDAEK-UHFFFAOYSA-N 0.000 description 1
- 108030003223 3-acetyloctanal synthases Proteins 0.000 description 1
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-hydroxypropionic acid Chemical compound OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- 108030003512 5-guanidino-2-oxopentanoate decarboxylases Proteins 0.000 description 1
- 108010002945 Acetoin dehydrogenase Proteins 0.000 description 1
- 108030005576 Acetoin-ribose-5-phosphate transaldolases Proteins 0.000 description 1
- 108010000700 Acetolactate synthase Proteins 0.000 description 1
- 102000009836 Aconitate hydratase Human genes 0.000 description 1
- 108010009924 Aconitate hydratase Proteins 0.000 description 1
- 108010070753 Adenosylmethionine decarboxylase Proteins 0.000 description 1
- 102000005758 Adenosylmethionine decarboxylase Human genes 0.000 description 1
- 208000000659 Autoimmune lymphoproliferative syndrome Diseases 0.000 description 1
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 description 1
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 description 1
- 108030003168 Benzoin aldolases Proteins 0.000 description 1
- 108010071778 Benzoylformate decarboxylase Proteins 0.000 description 1
- 101710117026 Biotin synthase Proteins 0.000 description 1
- 108030003513 Branched-chain-2-oxoacid decarboxylases Proteins 0.000 description 1
- 101710184216 Cardioactive peptide Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 108030004035 Cyclohexane-1,2-dione hydrolases Proteins 0.000 description 1
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 101000597679 Dictyostelium discoideum 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial Proteins 0.000 description 1
- 108010067193 Formaldehyde transketolase Proteins 0.000 description 1
- 241001191009 Gymnomyza Species 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- OHWCFZJEIHZWMN-LURJTMIESA-N N(2)-(2-carboxyethyl)-L-arginine Chemical compound NC(=[NH2+])NCCC[C@@H](C([O-])=O)[NH2+]CCC([O-])=O OHWCFZJEIHZWMN-LURJTMIESA-N 0.000 description 1
- 108030003974 Oxalate oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108010031852 Pyruvate Synthase Proteins 0.000 description 1
- 108010039491 Ricin Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 208000005428 Thiamine Deficiency Diseases 0.000 description 1
- 108010043652 Transketolase Proteins 0.000 description 1
- 102000014701 Transketolase Human genes 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 208000010045 Wernicke encephalopathy Diseases 0.000 description 1
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical class N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- DEDGUGJNLNLJSR-UHFFFAOYSA-N alpha-hydroxycinnamic acid Natural products OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 1
- 208000022379 autosomal dominant Opitz G/BBB syndrome Diseases 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 108010060155 deoxyxylulose-5-phosphate synthase Proteins 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 108010072869 indolepyruvate decarboxylase Proteins 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical class C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 108010032737 oxalyl CoA decarboxylase Proteins 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229960005222 phenazone Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000002990 phenothiazines Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 1
- 108010004621 phosphoketolase Proteins 0.000 description 1
- JKVUQLWTIZFTMF-UHFFFAOYSA-M potassium;2-oxopropanoate Chemical compound [K+].CC(=O)C([O-])=O JKVUQLWTIZFTMF-UHFFFAOYSA-M 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- SVLRFMQGKVFRTB-UHFFFAOYSA-M sodium;3-(3,5-dimethoxyanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].COC1=CC(NCC(O)CS([O-])(=O)=O)=CC(OC)=C1 SVLRFMQGKVFRTB-UHFFFAOYSA-M 0.000 description 1
- HDARHUHTZKLJET-UHFFFAOYSA-M sodium;3-(n-ethyl-3,5-dimethoxyanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC(OC)=CC(OC)=C1 HDARHUHTZKLJET-UHFFFAOYSA-M 0.000 description 1
- HLXGRHNZZSMNRX-UHFFFAOYSA-M sodium;3-(n-ethyl-3,5-dimethylanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC(C)=CC(C)=C1 HLXGRHNZZSMNRX-UHFFFAOYSA-M 0.000 description 1
- CJUDSKIRZCSXJA-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methoxyanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(OC)=C1 CJUDSKIRZCSXJA-UHFFFAOYSA-M 0.000 description 1
- MWFOPMKUGZLPQA-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methoxyanilino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CCCN(CC)C1=CC=CC(OC)=C1 MWFOPMKUGZLPQA-UHFFFAOYSA-M 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940066767 systemic antihistamines phenothiazine derivative Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- HZSAJDVWZRBGIF-UHFFFAOYSA-M thiamine(1+) monophosphate(2-) Chemical compound CC1=C(CCOP([O-])([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N HZSAJDVWZRBGIF-UHFFFAOYSA-M 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 150000004992 toluidines Chemical class 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
試料に対して、当該試料に含まれる測定対象物質を補酵素とする酵素と当該酵素の基質とを少なくとも添加して、当該酵素が触媒する化学反応により生成した生成物を測定し、当該生成物の測定量に基づいて、試料に含まれる測定対象物質を定量する。測定対象物質がチアミンであれば、酵素として例えばピルビン酸オキシダーゼを用い、基質としてピルビン酸を添加し、必要に応じて測定対象物質以外の補因子を添加して化学反応させる。生成物のうち過酸化水素を公知の方法で測定することにより、チアミンを定量することができる。To a sample, at least an enzyme having a substance to be measured contained in the sample as a coenzyme and a substrate of the enzyme are added, and a product generated by a chemical reaction catalyzed by the enzyme is measured. The measurement target substance contained in the sample is quantified based on the measurement amount of. When the substance to be measured is thiamine, for example, pyruvate oxidase is used as an enzyme, pyruvic acid is added as a substrate, and a cofactor other than the substance to be measured is added as needed to cause a chemical reaction. Thiamine can be quantified by measuring hydrogen peroxide in the product by a known method.
Description
本発明は、例えば、チアミン(ビタミンB1 )等のように補酵素として作用する生理活性物質を測定対象物質として測定する物質測定方法に関する。The present invention relates to a substance measuring method for measuring a physiologically active substance acting as a coenzyme such as thiamine (vitamin B 1 ) as a substance to be measured.
例えば、チアミン(ビタミンB1 )は、水溶性ビタミンの1種であり、糖質(炭水化物)および分岐鎖アミノ酸の代謝に大きく寄与するとともに、神経系、消化器系、心臓・血管系の機能調整にも寄与する。チアミンが欠乏すれば、脚気またはウェルニッケ脳症を引き起こすことが知られている。そのため、血液等の生体試料におけるチアミンの検査は、ビタミンB1 欠乏症の指標等として臨床的意義を有する。For example, thiamine (vitamin B 1 ) is a type of water-soluble vitamin, which greatly contributes to the metabolism of carbohydrates (carbohydrates) and branched-chain amino acids, and regulates the functions of the nervous system, digestive system, heart and blood vessels. Also contributes. It is known that thiamine deficiency causes beriberi or Wernicke encephalopathy. Therefore, the examination of thiamine in a biological sample such as blood has clinical significance as an indicator of vitamin B 1 deficiency and the like.
チアミンは、生体内ではリン酸化されてリン酸エステルとして存在しており、このリン酸エステルとしては、1リン酸エステルであるチアミン一リン酸(TMP)、2リン酸エステルであるチアミン二リン酸(チアミンピロリン酸、TPP)、3リン酸エステルであるチアミン三リン酸(TTP)が挙げられる。 Thiamine is phosphorylated in a living body and exists as a phosphoric acid ester. The phosphoric acid ester includes thiamine monophosphate (TMP), which is a monophosphate, and thiamine diphosphate, which is a diphosphate. (Thiamine pyrophosphate, TPP) and thiamine triphosphate (TTP) which is a triphosphate.
生体内では、チアミンの大部分がチアミン二リン酸で存在している。チアミン二リン酸は、α−カルボキシラーゼの補酵素であることから、コカルボキシラーゼとも称し、糖質の代謝に関与する補酵素、あるいは、生体内の種々酵素における補酵素として機能することが知られている。 In the living body, most of thiamine is present as thiamine diphosphate. Since thiamine diphosphate is a coenzyme of α-carboxylase, it is also called cocarboxylase, and is known to function as a coenzyme involved in carbohydrate metabolism or as a coenzyme in various enzymes in the living body. I have.
従来、チアミンの測定方法としては、主として、高速液体クロマトグラフィー(HPLC)が用いられてきた。代表的なポストカラム(ポストラベル)HPLC法では、まず、前処理として、試料に含まれるチアミンのリン酸エステルを加水分解し、リン酸エステルからリン酸を脱離させる。この前処理により、試料中の全てのチアミンはリン酸化されていないものとなる。このように前処理した試料はHPLCに注入されてカラムから溶出される。溶出時には溶出液にラベル化試薬を混合することで、溶出するチアミンの発色を検出器で検出することができる。 Conventionally, high-performance liquid chromatography (HPLC) has been mainly used as a method for measuring thiamine. In a typical post-column (post-label) HPLC method, first, as a pretreatment, a phosphoric acid ester of thiamine contained in a sample is hydrolyzed, and phosphoric acid is eliminated from the phosphoric acid ester. As a result of this pretreatment, all the thiamine in the sample is not phosphorylated. The sample thus pretreated is injected into the HPLC and eluted from the column. At the time of elution, by mixing a labeling reagent with the eluate, the color of the eluted thiamine can be detected by a detector.
また、最近では、ポストカラムHPLC法で想定される課題に対応するために、例えば、非特許文献1に開示されるように、液体クロマトグラフ−タンデム型質量分析計(LC/MS/MS)を用いたビタミンB1 (チアミン)測定方法(便宜上、LC/MS/MS法とする。)が提案されている。Also, recently, in order to cope with a problem assumed in the post-column HPLC method, for example, as disclosed in Non-Patent Document 1, a liquid chromatograph-tandem mass spectrometer (LC / MS / MS) is used. A method for measuring vitamin B 1 (thiamine) used (for convenience, LC / MS / MS method) has been proposed.
非特許文献1には、ポストカラムHPLC法の課題として、ラベル化試薬が強アルカリ性溶液であるため分析機器へのダメージが強いこと、廃液による環境負荷が懸念されていること、1試料(検体)当たりの測定時間が約10分を要するため効率的でないこと等が指摘されている。そこで、非特許文献1では、ビタミンB1 の測定方法としてLC/MS/MS法を用いることにより、ポストカラムHPLC法と同様の信憑性を有する測定結果が得られることを検証している。さらに、非特許文献1には、1試料当たりの測定時間を4分に短縮できること、強アルカリ性試薬を使用しないため分析機器へのダメージが軽減されるとともに環境への負荷も払拭されることが記載されている。Non-Patent Literature 1 states that the post-column HPLC method has problems that the labeling reagent is a strongly alkaline solution, which strongly damages an analytical instrument, and that there is a concern about an environmental load due to a waste liquid. It has been pointed out that the measurement time per hit takes about 10 minutes and is not efficient. Therefore, Non-Patent Document 1 verifies that the use of the LC / MS / MS method as a method for measuring vitamin B 1 can provide a measurement result having the same authenticity as the post-column HPLC method. Furthermore, Non-Patent Document 1 describes that the measurement time per sample can be reduced to 4 minutes, and that the use of a strongly alkaline reagent reduces damage to analytical instruments and eliminates the burden on the environment. Have been.
しかしながら、LC/MS/MS法であってもポストカラムHPLC法であっても、前処理としてリン酸を脱離させる加水分解が必要である。非特許文献1に記載されている通り、この前処理には例えば1時間もの長時間を要するため、チアミンの測定の効率化を妨げている。 However, in both the LC / MS / MS method and the post-column HPLC method, hydrolysis for removing phosphoric acid is required as a pretreatment. As described in Non-Patent Document 1, this pretreatment requires a long time of, for example, one hour, which hinders the efficiency of thiamine measurement.
また、非特許文献1によれば、LC/MS/MS法によるチアミンの測定では、ポストカラムHPLC法の測定に比べて1試料当たりの測定時間を短縮化できているが、この測定はバッチ処理(回分処理)であり連続処理ではない。そのため、連続処理の測定に比べて測定時間の短縮に限界がある。 According to Non-Patent Document 1, in the measurement of thiamine by the LC / MS / MS method, the measurement time per sample can be shortened as compared with the measurement by the post-column HPLC method. (Batch processing) and not continuous processing. Therefore, there is a limit in shortening the measurement time as compared with the measurement in the continuous processing.
本発明はこのような課題を解決するためになされたものであって、例えばチアミン(ビタミンB1 )のような生理活性物質を効率的に測定することができる物質測定方法を提供することを目的とする。The present invention has been made to solve such a problem, and an object of the present invention is to provide a substance measuring method capable of efficiently measuring a physiologically active substance such as thiamine (vitamin B 1 ). And
本発明に係る物質測定方法は、前記の課題を解決するために、試料に対して、当該試料に含まれる測定対象物質を補酵素とする酵素と当該酵素の基質とを少なくとも添加して、当該酵素が触媒する化学反応により生成した生成物を測定し、当該生成物の測定量に基づいて、前記試料に含まれる測定対象物質を定量する構成である。 In order to solve the above-described problems, the substance measurement method according to the present invention includes, for a sample, adding at least an enzyme having a target substance contained in the sample as a coenzyme and a substrate of the enzyme. A product generated by a chemical reaction catalyzed by an enzyme is measured, and a substance to be measured contained in the sample is quantified based on a measured amount of the product.
前記構成によれば、試料に含まれる測定対象物質を直接測定するのではなく、当該測定対象物質を補酵素とする酵素を用いて化学反応させ、この化学反応により生成した生成物を測定することにより、補酵素である測定対象物質を間接的に定量する。これにより、測定対象物質の直接測定する方法に比較して、当該測定対象物質の前処理を簡素化または省略することができる。そのため、測定対象物質を容易に測定することが可能となる。 According to the configuration, instead of directly measuring the measurement target substance contained in the sample, a chemical reaction is performed using an enzyme that uses the measurement target substance as a coenzyme, and a product generated by the chemical reaction is measured. Indirectly quantifies the substance to be measured, which is a coenzyme. This makes it possible to simplify or omit the pretreatment of the measurement target substance as compared with the method of directly measuring the measurement target substance. Therefore, the measurement target substance can be easily measured.
しかも、測定対象物質の濃度が相対的に低いとしても、生成物の測定量に基づいて測定対象物質を間接的に定量することで、直接的に定量する場合に比較して、当該測定対象物質をより高い感度で測定(定量)することが可能となる。それゆえ、本開示に係る物質測定方法を用いることにより、測定対象物質の濃度が低い試料であっても自動分析装置で測定する系の確立を進めることが可能となる。 Moreover, even if the concentration of the target substance is relatively low, the target substance is indirectly quantified based on the measured amount of the product. Can be measured (quantified) with higher sensitivity. Therefore, by using the substance measurement method according to the present disclosure, it is possible to promote establishment of a system for measuring even a sample having a low concentration of a measurement target substance by an automatic analyzer.
前記構成の物質測定方法においては、前記測定対象物質がチアミンである構成であってもよい。 In the substance measuring method having the above configuration, the measurement target substance may be thiamine.
また、前記構成の物質測定方法においては、前記化学反応を触媒する酵素がピルビン酸オキシダーゼであり、前記生成物が過酸化水素であるとともに、当該過酸化水素の測定は、当該過酸化水素とロイコ色素とをペルオキシダーゼの触媒作用により反応させ、これにより発色した当該ロイコ色素の呈色度を測定することにより行われる構成であってもよい。 Further, in the method for measuring a substance having the above constitution, the enzyme catalyzing the chemical reaction is pyruvate oxidase, the product is hydrogen peroxide, and the measurement of the hydrogen peroxide is performed by measuring the hydrogen peroxide and leuco. A configuration may be employed in which the reaction is performed by reacting a dye with a peroxidase catalysis and measuring the degree of coloration of the leuco dye that has developed color.
また、前記構成の物質測定方法においては、前記化学反応を触媒する酵素がピルビン酸オキシダーゼであり、前記生成物が過酸化水素であるとともに、当該過酸化水素の測定は、当該過酸化水素とアミノアンチピリンとトリンダー試薬とをペルオキシダーゼの触媒作用により反応させ、生成するキノン系色素による呈色度を測定することにより行われる構成であってもよい。 Further, in the substance measuring method having the above configuration, the enzyme that catalyzes the chemical reaction is pyruvate oxidase, the product is hydrogen peroxide, and the measurement of the hydrogen peroxide is performed by measuring the hydrogen peroxide and amino acid. A configuration in which antipyrine and a Trinder reagent are reacted by peroxidase catalysis, and the degree of coloration of the resulting quinone dye is measured may be employed.
また、前記構成の物質測定方法においては、前記測定対象物質が還元型のニコチンアミドアデニンジヌクレオチド(NADH)である構成であってもよい。 Further, in the substance measuring method having the above configuration, the target substance may be a reduced nicotinamide adenine dinucleotide (NADH).
また、前記構成の物質測定方法においては、前記化学反応を触媒する酵素が乳酸デヒドロゲナーゼであり、前記生成物が酸化型のニコチンアミドアデニンジヌクレオチド(NAD+)であるとともに、当該酸化型のニコチンアミドアデニンジヌクレオチドの測定は、吸光度変化により行われる構成であってもよい。 Further, in the substance measuring method having the above constitution, the enzyme catalyzing the chemical reaction is lactate dehydrogenase, the product is an oxidized nicotinamide adenine dinucleotide (NAD +), and the oxidized nicotinamide adenine is used. The measurement of the dinucleotide may be performed by a change in absorbance.
また、前記構成の物質測定方法においては、前記試料には、前記酵素および前記基質に加えて、前記測定対象物質以外の補因子を添加する構成であってもよい。 Further, in the substance measuring method having the above configuration, a configuration may be adopted in which a cofactor other than the substance to be measured is added to the sample in addition to the enzyme and the substrate.
本発明では、以上の構成により、例えばチアミン(ビタミンB1 )のような生理活性物質を効率的に測定することができる物質測定方法を提供することができる、という効果を奏する。According to the present invention, the configuration described above has an effect that a substance measuring method capable of efficiently measuring a physiologically active substance such as thiamine (vitamin B 1 ) can be provided.
以下、本開示の代表的な実施の形態を具体的に説明する。本開示に係る物質測定方法は、試料に対して、当該試料に含まれる測定対象物質を補酵素とする酵素と当該酵素の基質とを少なくとも添加して、当該酵素が触媒する化学反応により生成した生成物を測定する。そして、生成物の測定量に基づいて、試料に含まれる測定対象物質を定量する。 Hereinafter, typical embodiments of the present disclosure will be specifically described. The substance measurement method according to the present disclosure is such that a sample is obtained by adding at least an enzyme having a substance to be measured contained in the sample as a coenzyme and a substrate of the enzyme to a sample, and performing a chemical reaction catalyzed by the enzyme. Measure the product. Then, the substance to be measured contained in the sample is quantified based on the measured amount of the product.
本開示に係る物質測定方法における測定対象物質は具体的に限定されず、試料中に存在し補酵素として機能する生理活性物質であれば良い。具体的には、例えば、ビタミンB1 (チアミンまたはそのリン酸エステル)、ビタミンB2 (リボフラビンまたはそのヌクレオチド結合体)、ナイアシン(ニコチン酸またはニコチン酸アミドもしくはそのアデニンヌクレオチド結合体、ビタミンB3 とも称する)、ビタミンB6 (ピリドキシン、ピリドキサール、およびピリドキサミンまたはそのリン酸エステル)、補酵素A(パントテン酸)、補酵素R(ビオチン)、補酵素F(葉酸)、補酵素B12(コバラミン、ビタミンB12とも称する)、補酵素Q(ユビキノン)等のビタミン補酵素;ピロロキノリンキノン(PQQ)、トパキノン(TPQ)、トリプトファン−トリプトフィルキノン(TTQ)、:メチルアミン酸化還元、リシンチロシルキノン(LTQ)、システニル−トリプトファンキノン(CTQ)等のキノン補酵素;アデノシン三リン酸(ATP)、ウリジン二リン酸グルコース(UDPG)、ニコチンアミドアデニンジヌクレオチド(NADH/NAD+)等のヌクレオチド系補酵素(ビタミン補酵素のうちヌクレオチド結合体をヌクレオチド系補酵素に分類してもよい);α−リポ酸;等が挙げられる。The substance to be measured in the substance measuring method according to the present disclosure is not specifically limited, and may be a physiologically active substance that exists in a sample and functions as a coenzyme. Specifically, for example, vitamin B 1 (thiamine or its phosphate ester), vitamin B 2 (riboflavin or its nucleotide conjugate), niacin (nicotinic acid or nicotinamide or its adenine nucleotide conjugate, vitamin B 3) ), Vitamin B 6 (pyridoxine, pyridoxal, and pyridoxamine or its phosphate ester), coenzyme A (pantothenic acid), coenzyme R (biotin), coenzyme F (folate), coenzyme B12 (cobalamin, vitamin B 12 ), vitamin coenzymes such as coenzyme Q (ubiquinone); pyrroloquinoline quinone (PQQ), topaquinone (TPQ), tryptophan-tryptophyll quinone (TTQ), methylamine redox, ricin tyrosylquinone LTQ), cysteinyl-trip Fan quinone (CTQ) quinone coenzyme like; adenosine triphosphate (ATP), uridine diphosphate glucose (UDPG), nucleoside coenzyme such as nicotinamide adenine dinucleotide (NADH / NAD +) (vitamin coenzymes Of these, nucleotide conjugates may be classified as nucleotide coenzymes); α-lipoic acid; and the like.
本実施の形態では、測定対象物質として、ビタミンB1 すなわちチアミンまたはそのリン酸エステル(以下、単にチアミンとする。)を代表例に挙げて、本開示に係る物質測定方法を説明する(後述する実施例1参照)。In this embodiment, as the measurement target substance, vitamin B 1 That thiamine or a phosphoric acid ester (hereinafter, simply referred to. As thiamine) as an representative example, the substance measurement method according to the present disclosure will be described (to be described later See Example 1).
測定対象となる試料は特に限定されず、測定対象物質が含まれるものであればどのようなものであってもよい。測定対象物質がチアミンであれば、全血等の検体、チアミンを含む(可能性のある)食品等を挙げることができる。 The sample to be measured is not particularly limited, and may be any sample that contains the substance to be measured. When the substance to be measured is thiamine, a sample such as whole blood, a food containing (possibly) thiamine, and the like can be mentioned.
チアミンを補酵素とする酵素は特に限定されず、公知のものを好適に用いることができる。具体的には、例えば、ピルビン酸オキシダーゼ、ピルビン酸デヒドロゲナーゼ、3−メチル−2−オキソブタン酸デヒドロゲナーゼ、ピルビン酸シンターゼ、2−オキソグルタル酸シンターゼ、シュウ酸オキシドレダクターゼ、2−オキソ酸オキシドレダクターゼ、トランスケトラーゼ、ホルムアルデヒドトランスケトラーゼ、アセトイン−リボース−5−リン酸トランスアルドラーゼ、2−ヒドロキシ−3−オキソアジピン酸シンターゼ、アセト乳酸シンターゼ、1−デオキシ−D−キシルロース−5−リン酸シンターゼ、2−スクシニル−5−エノールピルビニル−6−ヒドロキシ−3−シクロヘキセン−1−カルボン酸シンターゼ、3−アセチルオクタナルシンターゼ、アセトインデヒドロゲナーゼ、スルホアセトアルデヒドアセチルトランスフェラーゼ、N2 −(2−カルボキシエチル)アルギニンシンターゼ、ビオチンシンターゼ、シクロヘキサン−1,2−ジオンヒドロラーゼ、ピルビン酸デカルボキシラーゼ、ベンゾイルギ酸デカルボキシラーゼ、オキサリル−CoAデカルボキシラーゼ、フェニルピルビン酸デカルボキシラーゼ、タルトロン酸−セミアルデヒドシンターゼ、アデノシルメチオニンデカルボキシラーゼ、2−オキソグルタレートデカルボキシラーゼ、分岐鎖−2−オキソ酸デカルボキシラーゼ、インドールピルビン酸デカルボキシラーゼ、5−グアニジノ−2−オキソペンタン酸デカルボキシラーゼ、スルホピルビン酸デカルボキシラーゼ、ホスホエノールピルビン酸デカルボキシラーゼ、ホスホケトラーゼ、フルクトース−6−リン酸ホスホケトラーゼ、プロピオンシンターゼ、ベンゾインアルドラーゼ、アコニット酸ヒドラターゼ、o−スクシニル安息香酸シンターゼ等が挙げられるが、特に限定されない。The enzyme using thiamine as a coenzyme is not particularly limited, and a known enzyme can be suitably used. Specifically, for example, pyruvate oxidase, pyruvate dehydrogenase, 3-methyl-2-oxobutanoate dehydrogenase, pyruvate synthase, 2-oxoglutarate synthase, oxalate oxidoreductase, 2-oxoacid oxidoreductase, transketolase , Formaldehyde transketolase, acetoin-ribose-5-phosphate transaldolase, 2-hydroxy-3-oxoadipate synthase, acetolactate synthase, 1-deoxy-D-xylulose-5-phosphate synthase, 2-succinyl- 5-enolpyrvinyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase, 3-acetyloctanal synthase, acetoindehydrogenase, sulfoacetaldehyde acetyl Lance Feller Ze, N 2 - (2-carboxyethyl) arginine synthase, biotin synthase, cyclohexane-1,2-dione hydrolase, pyruvate decarboxylase, benzoylformate decarboxylase, oxalyl -CoA decarboxylase, phenylpyruvic acid decarboxylase, tartronic Acid-semialdehyde synthase, adenosylmethionine decarboxylase, 2-oxoglutarate decarboxylase, branched-chain-2-oxoacid decarboxylase, indolepyruvate decarboxylase, 5-guanidino-2-oxopentanoate decarboxylase, sulfopyruvine Acid decarboxylase, phosphoenolpyruvate decarboxylase, phosphoketolase, fructose-6-phosphate phosphoketo Over Ze, propionic synthase, benzoin aldolase, aconitate hydratase, but like o- succinyl acid synthase include, but are not particularly limited.
また、チアミン(測定対象物質)を定量するために測定する生成物も特に限定されず、選択される酵素の種類に応じて適宜選択すればよい。同様に、生成物の測定方法も特に限定されず、生成物の種類に応じて公知の測定方法を採用すればよい。さらに、試料に対しては、酵素およびその基質を添加するだけでなく、他の成分、例えば測定対象物質以外の補因子を添加してもよい。 The product to be measured for quantifying thiamine (substance to be measured) is not particularly limited, and may be appropriately selected according to the type of the selected enzyme. Similarly, the method for measuring the product is not particularly limited, and a known measuring method may be employed depending on the type of the product. Further, to the sample, not only the enzyme and its substrate but also other components, for example, a cofactor other than the substance to be measured may be added.
本実施の形態では、酵素としてピルビン酸オキシダーゼを選択する場合を例に挙げて、本開示に係る物質測定方法をより具体的に説明する。ピルビン酸オキシダーゼは、ピルビン酸(CH3COCOOH )、リン酸(H3PO4)および酸素(O2 )を反応させて、アセチルリン酸(CH3 COH2PO4 )、二酸化炭素(CO2 )および過酸化水素(H2O2)を生成する化学反応を可逆的に触媒する。したがって、ピルビン酸オキシダーゼにおいては、ピルビン酸、リン酸、および酸素が基質であり、アセチルリン酸、二酸化炭素、および過酸化水素が生成物である。また、ピルビン酸オキシダーゼの補因子としては、補酵素であるチアミン(チアミン二リン酸)に加えて、フラビンアデニンジヌクレオチド(FAD)およびマグネシウムイオン(Mg2+ )が必要である。In the present embodiment, the substance measurement method according to the present disclosure will be described more specifically, taking as an example a case where pyruvate oxidase is selected as the enzyme. Pyruvate oxidase reacts pyruvate (CH 3 COCOOH), phosphoric acid (H 3 PO 4 ) and oxygen (O 2 ) to produce acetyl phosphate (CH 3 COH 2 PO 4 ), carbon dioxide (CO 2 ) And reversibly catalyze chemical reactions that produce hydrogen peroxide (H 2 O 2 ). Thus, in pyruvate oxidase, pyruvate, phosphate, and oxygen are substrates, and acetyl phosphate, carbon dioxide, and hydrogen peroxide are products. Further, as a cofactor for pyruvate oxidase, flavin adenine dinucleotide (FAD) and magnesium ion (Mg 2+ ) are required in addition to thiamine (thiamine diphosphate) as a coenzyme.
それゆえ、本開示に係る物質測定方法では、チアミンが含まれる(可能性のある)試料に対して、基質としてピルビン酸を添加するとともに、補因子として、FADおよびMg2+ を添加すればよい。また、酵素、基質、測定対象物質以外の補因子の添加方法も特に限定されない。例えば、試料が後述する実施例のように全血の検体であれば、酵素、基質、補因子を含む検出試薬を調製しておき、この検出試薬を試料に添加すればよい。Therefore, in the substance measurement method according to the present disclosure, pyruvic acid may be added as a substrate to a sample containing (possibly) thiamine, and FAD and Mg 2+ may be added as cofactors. . The method of adding cofactors other than the enzyme, the substrate, and the substance to be measured is not particularly limited. For example, if the sample is a sample of whole blood as in the examples described later, a detection reagent containing an enzyme, a substrate, and a cofactor may be prepared, and the detection reagent may be added to the sample.
ピルビン酸オキシダーゼにより触媒される前記化学反応では、生成物として、前記の通り、アセチルリン酸、二酸化炭素、および過酸化水素が生成するが、測定対象となる生成物はこれらのいずれであってもよい。本実施の形態では、過酸化水素を測定対象として選択するものとする。 In the chemical reaction catalyzed by pyruvate oxidase, acetyl phosphate, carbon dioxide, and hydrogen peroxide are generated as products as described above, and the product to be measured may be any of these. Good. In the present embodiment, hydrogen peroxide is selected as a measurement target.
生成物である過酸化水素を測定する方法は特に限定されないが、代表的には、ロイコ色素を用いる測定方法、あるいは、トリンダー試薬を用いる測定方法等が挙げられる。 The method for measuring hydrogen peroxide, which is a product, is not particularly limited, but typically includes a measurement method using a leuco dye, a measurement method using a Trinder reagent, and the like.
ロイコ色素を用いる測定方法では、過酸化水素とロイコ色素とをペルオキシダーゼの触媒作用により反応させ、これにより発色したロイコ色素の呈色度を測定することにより、過酸化水素を測定する。ロイコ色素は、酸化還元により発色したり消色したりする有機色素であり、過酸化水素1分子に対して反応する。 In the measurement method using a leuco dye, hydrogen peroxide is measured by reacting hydrogen peroxide with the leuco dye by the catalytic action of peroxidase, and measuring the degree of coloration of the leuco dye formed thereby. A leuco dye is an organic dye that develops or loses color by redox, and reacts with one molecule of hydrogen peroxide.
ロイコ色素の具体的な種類は特に限定されず、公知の化合物を好適に用いることができる。具体的には、例えば、10−(カルボキシメチルアミノカルボニル)−3,7−ビス(ジメチルアミノ)−10H−フェノチアジン塩(DA−67)、10−N−カルボキシメチルカルバモイル−3,7−ビス(ジメチルアミノ)−10H−フェノチアジン(CCAP)、10−(N−メチルカルバモイル)−3,7−ビス(ジメチルアミノ)−10H−フェノチアジン(MCDP)等のフェノチアジン誘導体;N,N,N’,N’,N’’,N’’−ヘキサ−(3−スルホプロピル)−4,4’,4’’−トリアミノトリフェニルメタン(TPM−PS)、4,4’−テトラメチルジアミノトリフェニルメタン(ロイコマラカイトグリーン)、トリス(4−ジメチルアミノフェニル)メタン(ロイコクリスタルバイオレット)等のトリフェニルメタン誘導体;N−(カルボキシメチルアミノカルボニル)−4,4’−ビス(ジメチルアミノ)ジフェニルアミン塩(DA−64)、4,4’−ビス(ジメチルアミノ)ジフェニルアミン、ビス[3−ビス(4−クロロフェニル)メチル−4−ジメチルアミノフェニル]アミン(BCMA)等のジフェニルアミン誘導体;ジアミノベンジジン、テトラメチルベンジジン等のベンジジン系化合物;o−フェニレンジアミン、ヒドロキシプロピオン酸等のその他の化合物;等を挙げることができる。これらの中でも、特に、DA−67,DA−64,TPM−PS,MCDP等が好適に用いられる。 The specific type of the leuco dye is not particularly limited, and a known compound can be suitably used. Specifically, for example, 10- (carboxymethylaminocarbonyl) -3,7-bis (dimethylamino) -10H-phenothiazine salt (DA-67), 10-N-carboxymethylcarbamoyl-3,7-bis ( Phenothiazine derivatives such as dimethylamino) -10H-phenothiazine (CCAP), 10- (N-methylcarbamoyl) -3,7-bis (dimethylamino) -10H-phenothiazine (MCDP); N, N, N ′, N ′ , N ", N" -hexa- (3-sulfopropyl) -4,4 ', 4 "-triaminotriphenylmethane (TPM-PS), 4,4'-tetramethyldiaminotriphenylmethane ( Trife such as leucomalachite green) and tris (4-dimethylaminophenyl) methane (leuco crystal violet) Methane derivative; N- (carboxymethylaminocarbonyl) -4,4′-bis (dimethylamino) diphenylamine salt (DA-64), 4,4′-bis (dimethylamino) diphenylamine, bis [3-bis (4- Diphenylamine derivatives such as chlorophenyl) methyl-4-dimethylaminophenyl] amine (BCMA); benzidine-based compounds such as diaminobenzidine and tetramethylbenzidine; and other compounds such as o-phenylenediamine and hydroxypropionic acid. it can. Among these, DA-67, DA-64, TPM-PS, MCDP and the like are particularly preferably used.
トリンダー試薬を用いる方法は、いわゆるトリンダー(Trinder)反応を利用する方法であり、過酸化水素とアミノアンチピリンとトリンダー試薬とをペルオキシダーゼの触媒作用により反応させ、生成するキノン系色素による呈色度を測定することにより、過酸化水素を測定する。トリンダー試薬は過酸化水素2分子に対して反応する。 The method using a Trinder reagent is a method that utilizes the so-called Trinder reaction, in which hydrogen peroxide, aminoantipyrine, and a Trinder reagent are reacted by the catalytic action of peroxidase, and the degree of coloration of the resulting quinone dye is measured. By doing so, hydrogen peroxide is measured. The Trinder reagent reacts with two molecules of hydrogen peroxide.
トリンダー試薬の具体的な種類は特に限定されず、公知の化合物を好適に用いることができる。具体的には、例えば、N−エチル−N−(2−ヒドロキシ−3−スルホプロピル)−3−メトキシアニリン(TOOS)、N−エチル−N−スルホプロピル-3-メトキシアニリン(ADPS)、N−エチル−N−-スルホプロピルアニリン(ALPS)、N−エチル−N−スルホプロピル−3−メチルアニリン(TOPS)、N−エチル−N−(2−ヒドロキシ−3−スルホプロピル)−3−メトキシアニリン(ADOS)、N−エチル−N−(2−ヒドロキシ−3−スルホプロピル)−3,5−ジメトキシアニリン(DAOS)、N−(2−ヒドロキシ−3−スルホプロピル)−3,5−ジメトキシアニリン(HDAOS)、N−エチル−N−(2−ヒドロキシ−3−スルホプロピル)−3,5−ジメチルアニリン(MAOS)等のアニリン誘導体;フェノール、4−クロロフェノール、2,4−ジクロロフェノール、2,6−ジクロロフェノール、3,5−ジクロロフェノール、2,4−ジブロモフェノール、2,4,6−トリクロロフェノール、2,4,6−トリブロモフェノール、3,5−ジクロロ−2−ヒドロキシベンゼンスルホン酸、または3−ヒドロキシ−2,4,6−トリヨードベンゾイル酸等のフェノール誘導体;トルイジン誘導体;等を挙げることができる。これらの中でも、特にTOOSが好適に用いられる。 The specific type of the Trinder reagent is not particularly limited, and a known compound can be suitably used. Specifically, for example, N-ethyl-N- (2-hydroxy-3-sulfopropyl) -3-methoxyaniline (TOOS), N-ethyl-N-sulfopropyl-3-methoxyaniline (ADPS), -Ethyl-N-sulfopropylaniline (ALPS), N-ethyl-N-sulfopropyl-3-methylaniline (TOPS), N-ethyl-N- (2-hydroxy-3-sulfopropyl) -3-methoxy Aniline (ADOS), N-ethyl-N- (2-hydroxy-3-sulfopropyl) -3,5-dimethoxyaniline (DAOS), N- (2-hydroxy-3-sulfopropyl) -3,5-dimethoxy Aniline induction such as aniline (HDAOS) and N-ethyl-N- (2-hydroxy-3-sulfopropyl) -3,5-dimethylaniline (MAOS) Conductor; phenol, 4-chlorophenol, 2,4-dichlorophenol, 2,6-dichlorophenol, 3,5-dichlorophenol, 2,4-dibromophenol, 2,4,6-trichlorophenol, 2,4 Phenol derivatives such as 6-tribromophenol, 3,5-dichloro-2-hydroxybenzenesulfonic acid, or 3-hydroxy-2,4,6-triiodobenzoyl acid; toluidine derivatives; and the like. Among these, TOOS is particularly preferably used.
本実施の形態では、測定対象物質がチアミンであるが、チアミンのようなビタミン補酵素は、生体中で非常に微量に存在するものであるため、試料中の濃度も相対的に低くなる。そのため、生成物の測定方法としては、生成物1分子に対して反応する方法を採用することで、より高感度の測定が可能である。ロイコ色素を用いる測定方法では、前記の通り過酸化水素1分子にロイコ色素が反応するが、トリンダー試薬を用いる測定方法では、前記の通り過酸化水素2分子に対してトリンダー試薬が反応するので、ロイコ色素を用いる測定方法を採用することがより好ましい。 In the present embodiment, the substance to be measured is thiamine, but since vitamin coenzyme such as thiamine is present in a very small amount in a living body, the concentration in the sample is relatively low. Therefore, by adopting a method of reacting one molecule of the product as a method of measuring the product, measurement with higher sensitivity is possible. In the measurement method using a leuco dye, as described above, the leuco dye reacts with one molecule of hydrogen peroxide. However, in the measurement method using a Trinder reagent, the Trinder reagent reacts with two molecules of hydrogen peroxide as described above. More preferably, a measurement method using a leuco dye is employed.
本実施の形態では、本開示に係る物質測定方法において、試料中のチアミン(ビタミンB1 )を測定する例を説明している。ここで、前述したように、チアミンは、生体内ではチアミン一リン酸(TMP)、2チアミン二リン酸(チアミンピロリン酸、TPP)、およびチアミン三リン酸(TTP)というリン酸エステルとして存在しており、その大部分がチアミン二リン酸である(リン酸化されていないチアミンも存在し得る)。そして、前述した実施の形態の方法では、補酵素であるチアミン二リン酸のみを測定していることになる。In the present embodiment, an example in which thiamine (vitamin B 1 ) in a sample is measured in the substance measurement method according to the present disclosure will be described. Here, as described above, thiamine exists in vivo as phosphate esters of thiamine monophosphate (TMP), 2 thiamine diphosphate (thiamine pyrophosphate, TPP), and thiamine triphosphate (TTP). And most of it is thiamine diphosphate (non-phosphorylated thiamine may also be present). Then, in the method of the above-described embodiment, only the coenzyme thiamine diphosphate is measured.
ここで、生体内における全チアミンのうちのチアミン二リン酸の比率については、従来の測定方法であるポストカラムHPLC法またはLC/MS/MS法によりを予め確認することができる。それゆえ、本開示に係る物質測定方法によるチアミン二リン酸の定量結果から、全チアミン中のチアミン二リン酸の比率を利用して、全チアミン量を検量することが可能になる。 Here, the ratio of thiamine diphosphate in the whole thiamine in the living body can be confirmed in advance by a conventional method such as a post-column HPLC method or an LC / MS / MS method. Therefore, from the quantification result of thiamine diphosphate by the substance measurement method according to the present disclosure, it is possible to calibrate the total thiamine amount using the ratio of thiamine diphosphate in all thiamine.
このように、本開示に係る物質測定方法では、試料に含まれる測定対象物質を直接測定するのではなく、当該測定対象物質を補酵素とする酵素を用いて化学反応させ、この化学反応により生成した生成物を測定することにより、補酵素である測定対象物質を間接的に定量する。これにより、測定対象物質の直接測定する方法に比較して、当該測定対象物質の前処理を簡素化または省略することができる。そのため、測定対象物質を容易に測定することが可能となる。 As described above, in the substance measurement method according to the present disclosure, instead of directly measuring the measurement target substance contained in the sample, a chemical reaction is performed using an enzyme having the measurement target substance as a coenzyme, and the chemical reaction is performed. By measuring the product thus obtained, the substance to be measured, which is a coenzyme, is indirectly determined. This makes it possible to simplify or omit the pretreatment of the measurement target substance as compared with the method of directly measuring the measurement target substance. Therefore, the measurement target substance can be easily measured.
しかも、チアミン等のようなビタミン補酵素は、試料中の濃度が低いが、このように測定対象物質の濃度が低い場合には、直接測定しようとしても十分な感度を実現できない可能性がある。これに対して、本開示によれば、生成物の測定量に基づいて測定対象物質を間接的に定量することで、当該測定対象物質をより高い感度で測定(定量)することが可能となる。 In addition, vitamin coenzymes such as thiamine and the like have low concentrations in the sample, but when the concentration of the substance to be measured is low, sufficient sensitivity may not be realized even if direct measurement is performed. On the other hand, according to the present disclosure, it is possible to measure (quantify) the measurement target substance with higher sensitivity by indirectly quantifying the measurement target substance based on the measurement amount of the product. .
また、一般に、試料中における測定対象物質の濃度が低すぎると、自動分析装置による測定に適用できる程度の感度を得ることができないおそれがある。しかしながら、本開示に係る物質測定方法によれば、チアミン等のような測定対象物質であっても、前記の通り、より高い感度での測定が可能になる。それゆえ、自動分析装置に適用可能な感度での測定を実現することができる。 In general, if the concentration of the substance to be measured in the sample is too low, there is a possibility that the sensitivity which can be applied to the measurement by the automatic analyzer may not be obtained. However, according to the substance measurement method according to the present disclosure, even with a measurement target substance such as thiamine, measurement with higher sensitivity is possible as described above. Therefore, measurement with sensitivity applicable to an automatic analyzer can be realized.
また、チアミン測定の場合では、従来の測定方法であるポストカラムHPLC法またはLC/MS/MS法では、バッチ処理による測定であるが、本開示に係る物質測定方法では、連続処理による測定が可能となる。加えて、ポストカラムHPLC法およびLC/MS/MS法のいずれであっても、検体(試料)中の全チアミン量を測定するために、チアミンリン酸エステルを加水分解してリン酸を脱離する前処理が必要になるが、本開示に係る物質測定方法では、全チアミンの大部分を占めるチアミン二リン酸を定量するだけで全チアミン量も定量することが可能になる。そのため、前処理としては、除タンパク程度の簡単な処理で済むことになる。それゆえ、本開示に係る物質測定方法を用いることにより、全血等の試料を簡単に前処理して自動分析装置で測定する測定系の確立を進めることが可能となる。 In addition, in the case of thiamine measurement, the post-column HPLC method or LC / MS / MS method, which is a conventional measurement method, is a measurement by a batch process, but the substance measurement method according to the present disclosure can be measured by a continuous process. Becomes In addition, in any of the post-column HPLC method and the LC / MS / MS method, in order to measure the total amount of thiamine in a specimen (sample), thiamine phosphate is hydrolyzed to desorb phosphoric acid. Although a pretreatment is required, the substance measurement method according to the present disclosure makes it possible to determine the total amount of thiamine only by quantifying thiamine diphosphate, which accounts for most of the total thiamine. Therefore, as the pre-processing, a simple processing such as the removal of protein is sufficient. Therefore, by using the substance measurement method according to the present disclosure, it becomes possible to easily establish a measurement system for pretreating a sample such as whole blood and measuring the sample with an automatic analyzer.
なお、本開示における他の実施の形態としては、測定対象物質が還元型のニコチンアミドアデニンジヌクレオチド(NADH)である形態を挙げることができる。NADH(測定対象物質)を定量するために測定する生成物も特に限定されず、選択される酵素の種類に応じて適宜選択すればよい。後述する実施例2では、酵素として乳酸デヒドロゲナーゼを用いており、この乳酸デヒドロゲナーゼは、基質であるピルビン酸を乳酸に変化させるとともに、補酵素であるNADHを酸化型のニコチンアミドアデニンジヌクレオチド(NAD+)に変化させる。なお、NADHを補酵素とする酵素は、乳酸デヒドロゲナーゼに限定されず、公知の他の酵素であってもよい。As another embodiment of the present disclosure, a form in which the substance to be measured is reduced nicotinamide adenine dinucleotide (NADH) can be mentioned. The product measured for quantifying NADH (substance to be measured) is not particularly limited, and may be appropriately selected depending on the type of the selected enzyme. In Example 2 described below, lactate dehydrogenase is used as an enzyme. This lactate dehydrogenase converts pyruvate as a substrate into lactic acid and converts NADH as a coenzyme into oxidized nicotinamide adenine dinucleotide (NAD + ). The enzyme using NADH as a coenzyme is not limited to lactate dehydrogenase, and may be another known enzyme.
したがって、本開示に係る物質測定方法では、NADHが含まれる(可能性のある)試料に対して、基質としてピルビン酸を添加すればよい。この場合、生成物として、前記の通り、乳酸およびNAD+が生成するが、測定対象となる生成物はこれらのいずれであってもよい。後述する実施例2ではNAD+を測定対象としている。NAD+が生成することでNADHが有する340nmの吸収ピークが減少するので、分光光度計で吸光度を測定することにより、試料中のNADHを定量することができる。Therefore, in the substance measurement method according to the present disclosure, pyruvate may be added as a substrate to a sample containing (possibly) NADH. In this case, as described above, lactic acid and NAD + are generated as the products, and the products to be measured may be any of these. In Example 2 to be described later, NAD + is measured. Since the generation of NAD + reduces the absorption peak at 340 nm of NADH, NADH in the sample can be quantified by measuring the absorbance with a spectrophotometer.
本発明について、実施例、比較例および参考例に基づいてより具体的に説明するが、本発明はこれに限定されるものではない。当業者は本発明の範囲を逸脱することなく、種々の変更、修正、および改変を行うことができる。 The present invention will be described more specifically based on Examples, Comparative Examples and Reference Examples, but the present invention is not limited to these. Those skilled in the art can make various changes, modifications, and alterations without departing from the scope of the present invention.
(実施例1)
[チアミン二リン酸溶液の調製]
コカルボキシラーゼ(チアミン二リン酸、和光純薬工業株式会社、製品番号:031−03833)を10mg秤量するとともに500mM−リン酸緩衝液(pH)を40mL分注して精製水で100mLに定容することで、100mg/L−チアミンピロリン酸のリン酸緩衝液(pH6.7)溶液を調製した。(Example 1)
[Preparation of thiamine diphosphate solution]
10 mg of cocarboxylase (thiamine diphosphate, Wako Pure Chemical Industries, Ltd., product number: 031-03833) is weighed, and 40 mL of 500 mM phosphate buffer (pH) is dispensed, and the volume is adjusted to 100 mL with purified water. Thus, a phosphate buffer solution (pH 6.7) solution of 100 mg / L-thiamine pyrophosphate was prepared.
[DA−67発色チアミンピロリン酸検出試薬の調製]
ピルビン酸オキシダーゼ(旭化成ファーマ株式会社、製品番号:T−45)を10ユニット、ペルオキシダーゼ(東洋紡株式会社、製品番号:PEO−301)を60ユニット、ピルビン酸カリウムを189mg、塩化マグネシウムを40mg、Triton X-100を20mgそれぞれ秤量するとともに、500mM−リン酸緩衝液(pH6.7)を4mL分注して精製水で10mLに定容することで、DA−67発色チアミンピロリン酸検出試薬の第一試薬(R1)を調製した。[Preparation of DA-67 colored thiamine pyrophosphate detection reagent]
10 units of pyruvate oxidase (Asahi Kasei Pharma Inc., product number: T-45), 60 units of peroxidase (Toyobo Co., product number: PEO-301), 189 mg of potassium pyruvate, 40 mg of magnesium chloride, Triton X By weighing 20 mg of each -100 mg and dispensing 4 mL of 500 mM phosphate buffer (pH 6.7) and making up to 10 mL with purified water, the first reagent of the DA-67 thiamine pyrophosphate detection reagent was developed. (R1) was prepared.
また、フラビンアデニンジヌクレオチド(FAD、和光純薬工業株式会社、製品番号:062−00164)を311mg、DA−67(和光純薬株式会社、製品番号:046−22341)を0.3mg、Triton X-100を10mgそれぞれ秤量するとともに、500mM−リン酸緩衝液(pH6.7)を2mL分注し、精製水で5mLに定容することで、DA−67発色チアミンピロリン酸検出試薬の第二試薬(R2)を調製した。 In addition, 311 mg of flavin adenine dinucleotide (FAD, Wako Pure Chemical Industries, Ltd., product number: 062-00164), 0.3 mg of DA-67 (Wako Pure Chemical Industries, Ltd., product number: 046-22341), and Triton X By weighing 10 mg each of -100 mg and dispensing 2 mL of 500 mM phosphate buffer (pH 6.7) and making up to 5 mL with purified water, the second reagent of DA-67 thiamine pyrophosphate detection reagent was developed. (R2) was prepared.
[標準液の調製および吸光度測定のブランク]
前述した100mg/L−チアミン二リン酸溶液を1mL,500mM−リン酸緩衝液(pH6.7)を400mL分注して精製水で1000mL(1L)に定容することで、検量線作成用の標準液(Tstd)を調製した。また、吸光度測定のブランク(空試験値、Blk)は、200mM−リン酸緩衝液(pH6.7)を用いた。[Blank for standard solution preparation and absorbance measurement]
1 mL of the above-mentioned 100 mg / L-thiamine diphosphate solution and 400 mL of a 500 mM phosphate buffer (pH 6.7) are dispensed, and the volume is adjusted to 1000 mL (1 L) with purified water to prepare a calibration curve. A standard solution (Tstd) was prepared. As a blank (blank test value, Blk) for absorbance measurement, 200 mM phosphate buffer (pH 6.7) was used.
ブランク用の200mM−リン酸緩衝液、標準液、および検体(全血、Tsam)を所定量分注し、それぞれ除タンパクのための前処理を行った。前処理では、それぞれに所定量のトリクロロ酢酸を添加して酸処理して上清を酢酸ナトリウム溶液で中和した。 A predetermined amount of a blank 200 mM phosphate buffer, a standard solution, and a sample (whole blood, Tsam) were dispensed, and each was pretreated for protein removal. In the pretreatment, a predetermined amount of trichloroacetic acid was added to each, and the mixture was acid-treated, and the supernatant was neutralized with a sodium acetate solution.
[吸光度変化の測定]
分光光度計として、株式会社日立ハイテクサイエンス社製、製品番号:U−3310を用い、ブランク(Blk)、標準液(Tstd)または検体(Tsam)と第一試薬(R1)と第二試薬(R2)とをそれぞれ1:6:2の比率で混合し(Blk/Tstd/Tsam:R1:R2=1:6:2)、波長700nm、温度37℃、タイムスキャン測定の測定条件で吸光度変化を測定した。[Measurement of change in absorbance]
Using a product number: U-3310 manufactured by Hitachi High-Tech Science Co., Ltd. as a spectrophotometer, a blank (Blk), a standard solution (Tstd) or a sample (Tsam), a first reagent (R1), and a second reagent (R2) ) Were mixed at a ratio of 1: 6: 2 (Blk / Tstd / Tsam: R1: R2 = 1: 6: 2), and the change in absorbance was measured under the measurement conditions of a wavelength of 700 nm, a temperature of 37 ° C., and a time scan measurement. did.
標準液の吸光度変化の結果および濃度の関係から検量線を作成した。また、この検量線を用いて検体に含まれるチアミン二リン酸の量を定量した。その結果、LC/MS/MS法と同様の検量線が作成できるとともに、LC/MS/MS法と同様に検体中のチアミン二リン酸の量を定量することができた。 A calibration curve was created from the results of the change in absorbance of the standard solution and the relationship between the concentrations. In addition, the amount of thiamine diphosphate contained in the sample was quantified using this calibration curve. As a result, a calibration curve similar to that of the LC / MS / MS method could be created, and the amount of thiamine diphosphate in the sample could be quantified similarly to the LC / MS / MS method.
(実施例2)
[NADH溶液の調製]
NADH(ナカライテスク株式会社製、製品番号:24335−61)は、Tris−HCl緩衝液として複数種類の濃度(31.25μM,62.5μM,125μM,250μM,500μM,1000μM)のものを調製した。また、吸光度測定のブランク用に、NADHを含有しないTris−HCl緩衝液のみ(NADHが0μM)を用いた。(Example 2)
[Preparation of NADH solution]
NADH (manufactured by Nacalai Tesque, Inc., product number: 24335-61) was prepared as a Tris-HCl buffer at a plurality of concentrations (31.25 μM, 62.5 μM, 125 μM, 250 μM, 500 μM, 1000 μM). For a blank for absorbance measurement, only a Tris-HCl buffer solution containing no NADH (NADH was 0 μM) was used.
[ピルビン酸溶液の調製]
10mMのTris−HCl緩衝液(pH9.5)に、ピルビン酸の濃度が2mMとなるように混合することで、第一試薬であるピルビン酸溶液を調製した。[Preparation of pyruvic acid solution]
By mixing with 10 mM Tris-HCl buffer (pH 9.5) so that the concentration of pyruvic acid becomes 2 mM, a pyruvic acid solution as the first reagent was prepared.
[乳酸デヒドロゲナーゼ溶液の調製]
20mMのTris−HCl緩衝液(pH7.0)に、乳酸デヒドロゲナーゼ(東洋紡株式会社製、製品名:LCD−209)の濃度が30ユニット/mLとなるように混合することで、第二試薬である乳酸デヒドロゲナーゼ溶液を調製した。[Preparation of lactate dehydrogenase solution]
The second reagent is mixed with 20 mM Tris-HCl buffer (pH 7.0) so that the concentration of lactate dehydrogenase (manufactured by Toyobo Co., Ltd., product name: LCD-209) becomes 30 units / mL. A lactate dehydrogenase solution was prepared.
[吸光度変化の測定]
測定対象の試料(サンプル)であるNADH溶液25μLと第一試薬450μLとを混合して吸光度測定用のA液を調製し、37℃で5分間加温した後に、A液の吸光度を測定した。その後、A液に対してさらに第二試薬を150μL混合して吸光度測定用のB液を調製し、37℃で5分間加温した後に、B液の吸光度を測定した。A液の吸光度をAbs.Aとし、B液の吸光度をAbs.Bとしたときに、吸光度変化ΔAbs.は、Abs.AとAbs.Bとの差分となる(ΔAbs.=Abs.A−Abs.B)。[Measurement of change in absorbance]
A solution A for absorbance measurement was prepared by mixing 25 μL of the NADH solution as a sample to be measured (sample) and 450 μL of the first reagent, and after heating at 37 ° C. for 5 minutes, the absorbance of the solution A was measured. Thereafter, 150 μL of the second reagent was further mixed with the A solution to prepare a B solution for absorbance measurement. After heating at 37 ° C. for 5 minutes, the absorbance of the B solution was measured. Abs. A, and the absorbance of the solution B is Abs. B, absorbance change ΔAbs. Is Abs. A and Abs. B (ΔAbs. = Abs.A−Abs.B).
濃度の異なるNADH溶液について、それぞれ吸光度変化ΔAbs.を測定し、NADH溶液の濃度と対比させたところ、図1に示すように、NADH濃度に対する吸光度変化ΔAbs.の変化が実質的に直線となっており、試料中のNADHを定量できることが明らかとなった。 For the NADH solutions having different concentrations, the absorbance change ΔAbs. Was measured and compared with the concentration of the NADH solution. As shown in FIG. 1, the absorbance change ΔAbs. Is substantially linear, indicating that NADH in the sample can be quantified.
なお、本発明は前記実施の形態の記載に限定されるものではなく、特許請求の範囲に示した範囲内で種々の変更が可能であり、異なる実施の形態や複数の変形例にそれぞれ開示された技術的手段を適宜組み合わせて得られる実施の形態についても本発明の技術的範囲に含まれる。 It should be noted that the present invention is not limited to the description of the above embodiments, and various changes can be made within the scope of the claims, and the present invention is disclosed in different embodiments and a plurality of modified examples. Embodiments obtained by appropriately combining the technical means described above are also included in the technical scope of the present invention.
また、上記説明から、当業者にとっては、本発明の多くの改良や他の実施形態が明らかである。従って、上記説明は、例示としてのみ解釈されるべきであり、本発明を実行する最良の態様を当業者に教示する目的で提供されたものである。本発明の精神を逸脱することなく、その構造及び/又は機能の詳細を実質的に変更できる。 From the above description, many modifications and other embodiments of the present invention are obvious to one skilled in the art. Accordingly, the above description is to be construed as illustrative only and is provided for the purpose of teaching those skilled in the art the best mode of carrying out the invention. Details of its structure and / or function may be substantially changed without departing from the spirit of the invention.
本発明は、試料中に含まれる補酵素として機能する物質を測定する分野に広く好適に用いることができる。 INDUSTRIAL APPLICABILITY The present invention can be widely and suitably used in the field of measuring a substance that functions as a coenzyme contained in a sample.
Claims (7)
当該生成物の測定量に基づいて、前記試料に含まれる測定対象物質を定量することを特徴とする、
物質測定方法。For a sample, at least an enzyme having a substance to be measured contained in the sample as a coenzyme and a substrate of the enzyme are added, and a product produced by a chemical reaction catalyzed by the enzyme is measured.
Based on the measured amount of the product, characterized by quantifying the measurement target substance contained in the sample,
Substance measurement method.
請求項1に記載の物質測定方法。The substance to be measured is thiamine,
The substance measuring method according to claim 1.
当該過酸化水素の測定は、当該過酸化水素とロイコ色素とをペルオキシダーゼの触媒作用により反応させ、これにより発色した当該ロイコ色素の呈色度を測定することにより行われることを特徴とする、
請求項2に記載の物質測定方法。The enzyme that catalyzes the chemical reaction is pyruvate oxidase, and the product is hydrogen peroxide,
The measurement of the hydrogen peroxide is performed by reacting the hydrogen peroxide with the leuco dye by the catalytic action of peroxidase, and measuring the degree of coloration of the leuco dye thus developed,
The method for measuring a substance according to claim 2.
当該過酸化水素の測定は、当該過酸化水素とアミノアンチピリンとトリンダー試薬とをペルオキシダーゼの触媒作用により反応させ、生成するキノン系色素による呈色度を測定することにより行われることを特徴とする、
請求項2に記載の物質測定方法。The enzyme that catalyzes the chemical reaction is pyruvate oxidase, and the product is hydrogen peroxide,
The measurement of the hydrogen peroxide is characterized in that the hydrogen peroxide, aminoantipyrine and a Trinder reagent are reacted by the catalytic action of peroxidase, and are measured by measuring the degree of coloration by a quinone-based dye to be produced.
The method for measuring a substance according to claim 2.
請求項1に記載の物質測定方法。The measurement target substance is reduced nicotinamide adenine dinucleotide (NADH),
The substance measuring method according to claim 1.
当該酸化型のニコチンアミドアデニンジヌクレオチドの測定は、吸光度変化により行われることを特徴とする、
請求項5に記載の物質測定方法。An enzyme that catalyzes the chemical reaction is lactate dehydrogenase, and the product is oxidized nicotinamide adenine dinucleotide (NAD +);
The measurement of the oxidized nicotinamide adenine dinucleotide is characterized by being performed by a change in absorbance,
The method for measuring a substance according to claim 5.
請求項1から6のいずれか1項に記載の物質測定方法。
The sample, in addition to the enzyme and the substrate, characterized by adding a cofactor other than the substance to be measured,
The method for measuring a substance according to claim 1.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017102944 | 2017-05-24 | ||
JP2017102944 | 2017-05-24 | ||
PCT/JP2018/019939 WO2018216757A1 (en) | 2017-05-24 | 2018-05-24 | Substance measurement method for measuring substance to be measured as coenzyme |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2018216757A1 true JPWO2018216757A1 (en) | 2020-03-26 |
JP7234923B2 JP7234923B2 (en) | 2023-03-08 |
Family
ID=64395561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019520301A Active JP7234923B2 (en) | 2017-05-24 | 2018-05-24 | Substance measurement method for measuring the substance to be measured as a coenzyme |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP7234923B2 (en) |
WO (1) | WO2018216757A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6368099A (en) * | 1986-09-10 | 1988-03-26 | Toyobo Co Ltd | Analyzing method by using pyruvic acid oxydase and reagent thereof |
JPH02200200A (en) * | 1988-10-07 | 1990-08-08 | Internatl Reagents Corp | Determining method of nadh and determination of bile acid using the same method |
JPH08168397A (en) * | 1994-12-19 | 1996-07-02 | Tokuyama Corp | Method for determining pyruvic acid and reagent for determining the same |
JPH1189594A (en) * | 1997-09-17 | 1999-04-06 | Fuji Photo Film Co Ltd | Dry-type analysis element for quantitative determination of pyruvic acid |
JP2003057235A (en) * | 2001-08-10 | 2003-02-26 | Internatl Reagents Corp | Method of stabilizing substance |
-
2018
- 2018-05-24 WO PCT/JP2018/019939 patent/WO2018216757A1/en active Application Filing
- 2018-05-24 JP JP2019520301A patent/JP7234923B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6368099A (en) * | 1986-09-10 | 1988-03-26 | Toyobo Co Ltd | Analyzing method by using pyruvic acid oxydase and reagent thereof |
JPH02200200A (en) * | 1988-10-07 | 1990-08-08 | Internatl Reagents Corp | Determining method of nadh and determination of bile acid using the same method |
JPH08168397A (en) * | 1994-12-19 | 1996-07-02 | Tokuyama Corp | Method for determining pyruvic acid and reagent for determining the same |
JPH1189594A (en) * | 1997-09-17 | 1999-04-06 | Fuji Photo Film Co Ltd | Dry-type analysis element for quantitative determination of pyruvic acid |
JP2003057235A (en) * | 2001-08-10 | 2003-02-26 | Internatl Reagents Corp | Method of stabilizing substance |
Non-Patent Citations (6)
Title |
---|
AKYILMAZ, EROL AND YORGANCI, EMINE: "A novel biosensor based on activation effect of thiamine on the activity of pyruvate oxidase", BIOSENSORS AND BIOELECTRONICS, vol. 23, JPN6018032717, 2008, pages 1874 - 1877, XP022666056, ISSN: 0004876781, DOI: 10.1016/j.bios.2008.03.001 * |
EDWARDS, KATIE A. ET AL.: "Thiamine Assays-Advances, Challenges, and Caveats", CHEMISTRYOPEN, PUBLISHED ONLINE ON MARCH 8, 2017, vol. 6, JPN6018032721, pages 178 - 191, XP055472007, ISSN: 0004876782, DOI: 10.1002/open.201600160 * |
SCHUBERT, FLORIAN ET AL.: "Lactate-Dehydrogenase-Based Biosensors for Glyoxylate and NADH Determination: A Novel Principle of A", ELECTROANALYSIS, vol. 2, JPN6018032716, 1990, pages 347 - 351, XP055563671, ISSN: 0004876780, DOI: 10.1002/elan.1140020504 * |
榊原香奈子 他: "酵素サイクリング法による血中乳酸およびピルビン酸の高感度微量測定", 臨床化学, vol. 29, JPN6018032727, 2000, pages 69 - 73, ISSN: 0004876779 * |
浅沼和子 他: "オキシダーゼ系を用いた血漿中乳酸・ピルビン酸の自動分析による新しい同時定量法", 生物試料分析, vol. 8, no. 3, JPN6018032724, 1985, pages 16 - 24, ISSN: 0004876783 * |
溝口誠 他: "臨床化学分析における新規な酸化及び還元発色試薬の開発", BUNSEKI KAGAKU, vol. 45, no. 2, JPN6018032726, 1996, pages 111 - 124, ISSN: 0004876784 * |
Also Published As
Publication number | Publication date |
---|---|
WO2018216757A1 (en) | 2018-11-29 |
JP7234923B2 (en) | 2023-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Seefeldt et al. | A continuous, spectrophotometric activity assay for nitrogenase using the reductant titanium (III) citrate | |
JP4807920B2 (en) | Total homocysteine measurement method | |
JP7234923B2 (en) | Substance measurement method for measuring the substance to be measured as a coenzyme | |
GB2213261A (en) | Assay of salicylates or reduced pyridine nucleatides | |
JP5327578B2 (en) | Method for measuring phosphatase | |
JP5017614B2 (en) | Method and reagent for measuring substance to be measured in sample, method for suppressing nonspecific color development, and nonspecific color development inhibitor | |
EP2460888B1 (en) | Method and kit for measurement of dehydrogenase or substrate for the dehydrogenase | |
US4695539A (en) | Process for quantitative determination of substrate treated with oxidase | |
JPS5935599B2 (en) | Cholinesterase activity measurement method | |
WO2012050536A1 (en) | Method of the adenosine diphosphate quantitative determination | |
JP2804079B2 (en) | Quantitative method of NAD (P) H | |
US5436133A (en) | Enzyme assay of biochemical substances | |
EP0386237B1 (en) | Enzyme assay of biological substances | |
JPH0231697A (en) | Analysis for measuring presence of substance to be analyzed test composition and test device | |
JP2000253898A (en) | Quantitative determination of substance or enzyme, and quantitative determining reagent | |
Sarfraz et al. | Enzyme assay techniques and protocols | |
US5447847A (en) | Quantitative determination of pyruvic acid and quantitative analysis for component of living body making use of such determination | |
JP7330516B2 (en) | Method for measuring 2-aminophenols | |
US20220112537A1 (en) | Stabilization of nadph or nadh in ammonia detection assays | |
WO2023074687A1 (en) | Method for measuring pyrophosphoric acid or phosphoribosyl pyrophosphate, measurement composition and reagent kit for measuring same, and amplification method thereof | |
EP0138530A2 (en) | Method for the estimation of salicylates or reduced Pyridine nucleotides | |
JP2001252095A (en) | Method for assaying trace component and composition used therefor | |
JP2618456B2 (en) | Dinucleotide quantification method | |
JPH047200B2 (en) | ||
JPH1146795A (en) | Oxidase-containing reagent for analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210420 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220412 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220610 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220920 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221109 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230124 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230206 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7234923 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |